Videos de Experimentos Relacionados
El síndrome del intestino irritable.
Lancet (London, England)
|February 27, 1993
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Single-center Clinical Experience of Diarrhea in Patients Treated With Sorafenib Shows Rare Development of Pancreatic Atrophy.
Gastro hep advances·2024
Same author
Rectal Evacuation Disorders in Patients Presenting With Chronic Functional Diarrhea.
Gastro hep advances·2024
Same author
Comparison of Quality of Life and Psychiatric Symptoms Between Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Those With Constipation-Predominant Irritable Bowel Syndrome.
Gastro hep advances·2023
Same author
Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans.
Neurogastroenterology and motility·2018
Same author
Reproducibility of gastric emptying assessed with scintigraphy in patients with upper GI symptoms.
Neurogastroenterology and motility·2018
Same author
Comparison of pH and motility of the small intestine of healthy subjects and patients with symptomatic constipation using the wireless motility capsule.
International journal of pharmaceutics·2018
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026